HLTH
CUE HEALTH INC (HLTH)
$36.76%▲
Market is closedMarket is closed – opens on 8 PM, 01 Dec 2022
– opens on 8 PM, 01 Dec 2022
Key Stats
$2.71
Day's Range
$3.0
$2.42
52-Week Range
$16.2
| Returns | |
| 1 month return | 29.22% |
| 3 month return | 15.62% |
| 1 year return | 75.02% |
| 5 year return | 85.95% |
Company Information
Cue Health is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, and regulatory approval from India’s Central Drugs Standard Control Organisation. Cue Health was founded in 2010 and is headquartered in San Diego.
| Organization | CUE HEALTH INC |
| Employees | 1585 |
| CEO | Mr. Ayub K. Khattak |
| Industry | Health Services |
Analyst Recommendation
based on 4 analysts ratings
Buy
75%
Buy
25%
Hold
0%
Sell
Based on 4 Wall street analysts offering stock ratings for CUE HEALTH INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 119.59%Current
$2.96
Target
$6.5
Recommendation Trend
Based on 4 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 3 | 8 | 8 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 393.0M |
| Book Value | $3.96 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 0.21 |
| PE Ratio | 12.52 |
| Wall Street Target Price | 6.5 |
Valuation
| Trailing PE | 12.52 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 0.63 |
| Enterprise Value | 123.9M |
| Enterprise Value/Revenue | 0.24 |
| Enterprise Value/Ebitda | -1.2 |
Technicals
| 50 Day MA | 3.35 |
| 200 Day MA | 4.99 |
Institutional Holdings
Koch Industries Inc
8.83%
Oakmont Corp
6.43%
Johnson & Johnson
3.72%
Jabodon PT Co
3.07%
Vanguard Group Inc
2.71%
Temasek Holdings Ltd.
2.09%
Discover more
Frequently Asked Questions
What is CUE HEALTH INC share price today?
Can Indians buy CUE HEALTH INC shares?
How can I buy CUE HEALTH INC shares from India?
Can Fractional shares of CUE HEALTH INC be purchased?
What are the documents required to start investing in CUE HEALTH INC stocks?
What are today’s High and Low prices of CUE HEALTH INC?
What are today’s traded volumes of CUE HEALTH INC?
What is today’s market capitalisation of CUE HEALTH INC?
What is the 52 Week High and Low Range of CUE HEALTH INC?
How much percentage CUE HEALTH INC is down from its 52 Week High?
How much percentage CUE HEALTH INC is up from its 52 Week low?
What are the historical returns of CUE HEALTH INC?
Who is the Chief Executive Officer (CEO) of CUE HEALTH INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*